Difference between revisions of "Team:EPF Lausanne/Timeline"
Line 134: | Line 134: | ||
<div class="first-section"> | <div class="first-section"> | ||
<ul class="timeline"> | <ul class="timeline"> | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
<li class="timeline-inverted"> | <li class="timeline-inverted"> | ||
− | |||
<div class="timeline-panel"> | <div class="timeline-panel"> | ||
<div class="timeline-heading"> | <div class="timeline-heading"> | ||
Line 154: | Line 141: | ||
<div class="timeline-body"> | <div class="timeline-body"> | ||
<p>Mussum ipsum cacilds, vidis litro abertis. Consetis adipiscings elitis. Pra lá , depois divoltis porris, paradis. Paisis, filhis, espiritis santis. Mé faiz elementum girarzis, nisi eros vermeio, in elementis mé pra quem é amistosis quis leo. Manduma pindureta quium dia nois paga. Sapien in monti palavris qui num significa nadis i pareci latim. Interessantiss quisso pudia ce receita de bolis, mais bolis eu num gostis.</p> | <p>Mussum ipsum cacilds, vidis litro abertis. Consetis adipiscings elitis. Pra lá , depois divoltis porris, paradis. Paisis, filhis, espiritis santis. Mé faiz elementum girarzis, nisi eros vermeio, in elementis mé pra quem é amistosis quis leo. Manduma pindureta quium dia nois paga. Sapien in monti palavris qui num significa nadis i pareci latim. Interessantiss quisso pudia ce receita de bolis, mais bolis eu num gostis.</p> | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
</div> | </div> | ||
</div> | </div> | ||
Line 234: | Line 175: | ||
<div class="timeline-body"> | <div class="timeline-body"> | ||
<p>In our project dCas9 target DNA sequences using gRNAs and acts as an activator or an inhibitor depending on its position. Axel and Cyril created a C++ program to blast random generated gRNA sequences on the E. Coli or Yeast genome.</p> | <p>In our project dCas9 target DNA sequences using gRNAs and acts as an activator or an inhibitor depending on its position. Axel and Cyril created a C++ program to blast random generated gRNA sequences on the E. Coli or Yeast genome.</p> | ||
+ | <hr> | ||
+ | <div class="btn-group"> | ||
+ | <button type="button" class="btn btn-primary btn-sm dropdown-toggle" data-toggle="dropdown"> | ||
+ | <i class="glyphicon glyphicon-cog"></i> <span class="caret"></span> | ||
+ | </button> | ||
+ | <ul class="dropdown-menu" role="menu"> | ||
+ | <li><a href="" target="blank">Wiki</a></li> | ||
+ | <li class="divider"></li> | ||
+ | <li><a href="" target="blank">Download</a></li> | ||
+ | </ul> | ||
+ | </div> | ||
+ | |||
</div> | </div> | ||
</div> | </div> | ||
Line 270: | Line 223: | ||
</div> | </div> | ||
<div class="timeline-body"> | <div class="timeline-body"> | ||
− | <p>Three cool ideas came out of the brainstorming: new framework for biologic circuits or lung cancer therapy using dCas9 and cell-cell communication.</p> | + | <p>Three cool ideas came out of the brainstorming: a new framework for biologic circuits or lung cancer therapy using dCas9 and cell-cell communication through exosomes.</p> |
</div> | </div> | ||
</div> | </div> | ||
Line 282: | Line 235: | ||
</div> | </div> | ||
<div class="timeline-body"> | <div class="timeline-body"> | ||
− | <p>The team is split | + | <p>The team is split into small groups, brainstorming for an interesting project that will occupy us during the summer.</p> |
</div> | </div> | ||
</div> | </div> | ||
Line 295: | Line 248: | ||
<div class="timeline-body"> | <div class="timeline-body"> | ||
<p>First meeting with everyone: 12 teammates, 7 TAs and 3 advisors.</p> | <p>First meeting with everyone: 12 teammates, 7 TAs and 3 advisors.</p> | ||
+ | <img src="https://static.igem.org/mediawiki/2015/2/2e/Team_All.jpg" width="750" class="displayed"> | ||
</div> | </div> | ||
</div> | </div> |
Revision as of 09:16, 29 July 2015
Timeline
-
Mussum ipsum cacilds
Mussum ipsum cacilds, vidis litro abertis. Consetis adipiscings elitis. Pra lá , depois divoltis porris, paradis. Paisis, filhis, espiritis santis. Mé faiz elementum girarzis, nisi eros vermeio, in elementis mé pra quem é amistosis quis leo. Manduma pindureta quium dia nois paga. Sapien in monti palavris qui num significa nadis i pareci latim. Interessantiss quisso pudia ce receita de bolis, mais bolis eu num gostis.
-
The bible
The E. Coli part of our project is strongly based on the papar of Bikard et al. "Programmable repression and activation of bacterial gene expression using an engineered CRISPR-Cas system". Bikard sent us his strains JEN202, JEN202+PWJ89 and DH5A+PWJ66. We also ordered a plasmid containing dCas9 and the synthetic DNA encoding fou our gRNAs.
-
Blast
02.04.2015
In our project dCas9 target DNA sequences using gRNAs and acts as an activator or an inhibitor depending on its position. Axel and Cyril created a C++ program to blast random generated gRNA sequences on the E. Coli or Yeast genome.
-
And the winner is...
26.03.2015
...the new framework for biologic circuits using dCas9.
-
The lab starts!
24.03.2015 - 26.03.2015
TAs start to train us in the lab: medium and agar plates preparation
-
Brainstorming finalists
19.03.2015
Three cool ideas came out of the brainstorming: a new framework for biologic circuits or lung cancer therapy using dCas9 and cell-cell communication through exosomes.
-
Brainstorming
26.02.2015 - 12.03.2015
The team is split into small groups, brainstorming for an interesting project that will occupy us during the summer.
-
First meeting: iGEM officially starts!
19.02.2015
First meeting with everyone: 12 teammates, 7 TAs and 3 advisors.